| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.0008 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |